E-LIB Suche - Ergebnisse für: Mertens, Joachim C

1

Evaluation of soluble suppression of tumorigenicity 2 (sST2..:

Hildenbrand, Florian F. ; Illi, Barbara ; von Felten, Stefanie...
BMC Gastroenterology. 24 (2024) 1 - p. , 2024

Link: https://doi.org/10.1186/..

2

Immunotherapy of Biliary Tract Cancer:

, In: Immune Strategies for Gastrointestinal Cancer; Cancer Immunotherapy,

Mertens, Joachim C. ; Fritsch, Ralph - p. 187-206 , 2023

Link: https://doi.org/10.1007/..

3

Validation of the CRAFITY score in patients with hepatocell..:

Scheiner, Bernhard ; Sartoris, Riccardo ; D'Alessio, Antonio...
Journal of Hepatology. 78 (2023) - p. S491-S492 , 2023

Link: https://doi.org/10.1016/..

4

Darmkrebsscreening in Zeiten von COVID-19: Verpasste Karzin..:

Mertens, Joachim C.
Schweizer Gastroenterologie. 3 (2022) 3 - p. 121-122 , 2022

Link: https://doi.org/10.1007/..

5

Prognosis of patients with hepatocellular carcinoma treated..:

Scheiner, Bernhard ; Pomej, Katharina ; Kirstein, Martha M....
Journal of Hepatology. 76 (2022) 2 - p. 353-363 , 2022

Link: https://doi.org/10.1016/..

6

A single nucleotide polymorphism in the gene for GPR183 inc..:

Ruiz, Florian ; Wyss, Annika ; Rossel, Jean‐Benoît...
British Journal of Pharmacology. 178 (2021) 16 - p. 3157-3175 , 2021

Link: https://doi.org/10.1111/..

7

Rates of Hepatocellular Carcinoma After Start of Treatment ..:

Karbeyaz, Fatih ; Kissling, Seraphina ; Jaklin, Paul Julius...
Journal of Hepatocellular Carcinoma. 8 (2021) - p. 565-574 , 2021

Link: https://doi.org/10.2147/..

8

Pleiotropic Effects of Atorvastatin Result in a Downregulat..:

Claesen, Karen ; Roth, Lynn ; Mertens, Joachim C....
Pharmaceutics. 13 (2021) 10 - p. 1731 , 2021

Link: https://doi.org/10.3390/..

9

Carboxypeptidase U (CPU, TAFIa, CPB2) in Thromboembolic Dis..:

Claesen, Karen ; Mertens, Joachim C. ; Leenaerts, Dorien.
International Journal of Molecular Sciences. 22 (2021) 2 - p. 883 , 2021

Link: https://doi.org/10.3390/..

10

Effect of Statin Therapy on the Carboxypeptidase U (CPU, TA..:

Claesen, Karen ; Mertens, Joachim C. ; Basir, Shahir...
Clinical Therapeutics. 43 (2021) 5 - p. 908-916 , 2021

Link: https://doi.org/10.1016/..

11

Carboxypeptidase U (TAFIa) Is Rapidly Activated and Deactiv..:

Mertens, Joachim C. ; Blanc-Guillemaud, Vanessa ; Claesen, Karen...
Translational Stroke Research. 13 (2021) 6 - p. 959-969 , 2021

Link: https://doi.org/10.1007/..

12

The Tumor Environment: Cholangiocarcinoma-Associated Fibrob..:

, In: Diagnosis and Management of Cholangiocarcinoma,

Moncsek, Anja ; Mertens, Joachim C. - p. 509-526 , 2021

Link: https://doi.org/10.1007/..

13

Cholangiocarcinoma 2020: the next horizon in mechanisms and..:

Banales, Jesus M. ; Marin, Jose J. G. ; Lamarca, Angela...
Nature Reviews Gastroenterology & Hepatology. 17 (2020) 9 - p. 557-588 , 2020

Link: https://doi.org/10.1038/..

14

Selective inhibition of carboxypeptidase U may reduce micro..:

Mertens, Joachim C. ; Boisseau, William ; Leenaerts, Dorien...
Journal of Thrombosis and Haemostasis. 18 (2020) 12 - p. 3325-3335 , 2020

Link: https://doi.org/10.1111/..

15

Histological primary biliary cholangitis changes in patient..:

Costantini, Silvia ; Cerny, Andreas ; Stirnimann, Guido...
Journal of Hepatology. 73 (2020) - p. S461-S462 , 2020

Link: https://doi.org/10.1016/..